BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0120
+0.0020 (20.00%)
Jan 20, 2026, 9:30 AM EST
BioRegenx Market Cap
BioRegenx has a market cap or net worth of $13.47 million as of January 23, 2026. Its market cap has decreased by -55.30% in one year.
Market Cap
13.47M
Enterprise Value
15.68M
Revenue
1.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since March 12, 2024, BioRegenx's market cap has decreased from 49.89M to 13.47M, a decrease of -73.00%. That is a compound annual growth rate of -50.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 11.54M | -6.98% |
| Dec 31, 2025 | 12.41M | 44.15% |
| Dec 31, 2024 | 8.61M | -82.74% |
| Mar 12, 2024 | 49.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veri Medtech Holdings | 31.66M |
| Vaso Corporation | 30.62M |
| DATATRAK International | 21.35M |
| Resilient Healthcare | 13.99M |
| CareView Communications | 12.32M |
| Pharma-Bio Serv | 10.60M |
| PreAxia Health Care Payment Systems | 9.47M |
| Vynleads | 5.79M |